{"id":32415,"date":"2024-04-17T11:12:18","date_gmt":"2024-04-17T09:12:18","guid":{"rendered":"https:\/\/www.thema-med.com\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/"},"modified":"2024-04-18T16:08:25","modified_gmt":"2024-04-18T14:08:25","slug":"brasile-estensione-a-quattro-anni-dei-b-gmp","status":"publish","type":"post","link":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/","title":{"rendered":"BRAZIL: B-GMP Extended to Four Years"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1144px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><h2>On March 20, 2024, the Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria <strong>(ANVISA)<\/strong> officially extended the validity of Brazilian Good Manufacturing Practice<strong> (B-GMP)<\/strong> certificates to <strong>four years <\/strong>for manufacturers participating in the Medical Device Single Audit Programme (MDSAP), and this extension took effect on <strong>April 1, 2024<\/strong>.<\/h2>\n<p>Specifically, ANIVSA published <strong>Resolution RDC 850\/2024<\/strong> amending Article 8 of RDC 497\/2021 and officially extending the B-GMP certificate <strong>from two to four years <\/strong>for manufacturers participating in the MDSAP programme. Naturally, the manufacturer must maintain its MDSAP certificate for the duration of the B-GMP certificate.<\/p>\n<p>In addition, a <strong>manufacturer <\/strong>who has applied for the renewal of its B-GMP certificate but has not yet received final approval from ANVISA before Resolution 850\/2024 comes into force <strong>may<\/strong> still <strong>benefit from<\/strong> the four-year B-GMP extension.<\/p>\n<p>The extension of the validity of B-GMP certificates from 2 years to 4 years is a very important innovation because it further increases the <strong>benefits<\/strong> of MDSAP certification and <strong>reduces<\/strong> regulatory costs.<\/p>\n<p>In addition, ANVISA announced that DRC 830\/2023 will come into force on <strong>June 1, 2024<\/strong>, whereby it will ask manufacturers to close the gaps between DRC 36\/2015 and DRC 830\/2023.<\/p>\n<p>Specifically, on March 25, 2024, the Brazilian regulatory authority published three guidance documents for RDC 830\/2023:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/centraisdeconteudo\/publicacoes\/produtos-para-a-saude\/manuais\/perguntas-respostas-rdc-830-de-2023\/view\"><em>Q&amp;A on RDC 830\/2023<\/em><\/a>;<\/li>\n<li><a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/centraisdeconteudo\/publicacoes\/produtos-para-a-saude\/manuais\/rdc-830-2023-nomes-tecnicos-mudanca-de-classe-de-risco\/view\"><em>IVDs with risk classifications that have changed<\/em><\/a>;<\/li>\n<li><a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/centraisdeconteudo\/publicacoes\/produtos-para-a-saude\/manuais\/rdc-830-23-nomes-tecnicos-associados-a-mais-de-uma-classe-de-risco\/view\"><em>IVDs with more than one risk classification<\/em><\/a>.<\/li>\n<\/ul>\n<p><strong><em>Q&amp;A on RDC 830\/2023<\/em><\/strong> is organised into chapters on specific topics and presents ANVISA&#8217;s answers to questions posed on RDC 830\/2023. <strong><em>IVDs with risk<\/em> <em>classifications<\/em> <em>that have<\/em> <em>changed<\/em><\/strong> describes how the classification of devices has changed. Consequently, manufacturers are required to carry out classification revisions. Finally, <strong><em>IVDs with<\/em> <em>more than one risk classification<\/em> <\/strong>also describes IVD devices with more than one risk class.<\/p>\n<p>Manufacturers are therefore encouraged to <strong>carry out a gap assessment between RDC 36\/2015 and RDC 830\/2023<\/strong>, going, in particular, to review the classification of their IVDs.<\/p>\n<p>Through the <strong>extension of B-GMP<\/strong>, ANVISA wants to make MDSAP certification more advantageous, to induce more manufacturers to market their devices in Brazil.<\/p>\n<p>The entry into force of RDC 830\/2023 demonstrates that ANVISA wants to keep the regulations governing IVD devices in step with those of other countries, such as the USA and Europe, to guarantee its users and patients the best technology.<\/p>\n<p>&gt;&gt;&gt; Through the services of\u00a0<a href=\"https:\/\/www.thema-med.com\/servizi-consulenza-strategico-regolatoria-aziende-dispositivi-medici-strumenti-medicali-dispositivi-medico-diagnostici-in-vitro\/consulenza-strategico-regolatoria-dispositivi-medici-medical-devices\/\"><strong>strategic-regulatory consulting<\/strong><\/a>\u00a0 Thema supports the <a href=\"https:\/\/www.thema-med.com\/servizi-consulenza-strategico-regolatoria-aziende-dispositivi-medici-strumenti-medicali-dispositivi-medico-diagnostici-in-vitro\/local-representative-mercati-esteri\/\"><strong>registration with ANVISA <\/strong><\/a>\u00a0\u00a0for the marketing of medical devices and IVDs in Brazil.<\/p>\n<p><strong>Source<\/strong><\/p>\n<p><a href=\"https:\/\/www.in.gov.br\/en\/web\/dou\/-\/resolucao-da-diretoria-colegiada-rdc-n-850-de-20-de-marco-de-2024-549594756\">Resolution RDC 850\/2024<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":115,"featured_media":32373,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-32415","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BRAZIL: B-GMP Extended to Four Years<\/title>\n<meta name=\"description\" content=\"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRAZIL: B-GMP Extended to Four Years\" \/>\n<meta property=\"og:description\" content=\"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/\" \/>\n<meta property=\"og:site_name\" content=\"Thema Med\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T09:12:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-18T14:08:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ufficiomarketing\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ufficiomarketing\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/\"},\"author\":{\"name\":\"ufficiomarketing\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d\"},\"headline\":\"BRAZIL: B-GMP Extended to Four Years\",\"datePublished\":\"2024-04-17T09:12:18+00:00\",\"dateModified\":\"2024-04-18T14:08:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/\"},\"wordCount\":642,\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/\",\"url\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/\",\"name\":\"BRAZIL: B-GMP Extended to Four Years\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg\",\"datePublished\":\"2024-04-17T09:12:18+00:00\",\"dateModified\":\"2024-04-18T14:08:25+00:00\",\"description\":\"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#primaryimage\",\"url\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg\",\"contentUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"xr:d:DAGB0iy_isI:24,j:6459711983316665026,t:24040810\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/www.thema-med.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRAZIL: B-GMP Extended to Four Years\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"name\":\"Thema Med\",\"description\":\"Quality and Regulatory Affairs for Medical Devices\",\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thema-med.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\",\"name\":\"Thema\",\"alternateName\":\"Thema\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"contentUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"width\":2440,\"height\":2851,\"caption\":\"Thema\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/\"],\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d\",\"name\":\"ufficiomarketing\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g\",\"caption\":\"ufficiomarketing\"},\"url\":\"https:\/\/www.thema-med.com\/en\/author\/ufficiomarketing\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRAZIL: B-GMP Extended to Four Years","description":"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/","og_locale":"en_US","og_type":"article","og_title":"BRAZIL: B-GMP Extended to Four Years","og_description":"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature","og_url":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/","og_site_name":"Thema Med","article_published_time":"2024-04-17T09:12:18+00:00","article_modified_time":"2024-04-18T14:08:25+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg","type":"image\/jpeg"}],"author":"ufficiomarketing","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ufficiomarketing","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#article","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/"},"author":{"name":"ufficiomarketing","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d"},"headline":"BRAZIL: B-GMP Extended to Four Years","datePublished":"2024-04-17T09:12:18+00:00","dateModified":"2024-04-18T14:08:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/"},"wordCount":642,"publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/","url":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/","name":"BRAZIL: B-GMP Extended to Four Years","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#primaryimage"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg","datePublished":"2024-04-17T09:12:18+00:00","dateModified":"2024-04-18T14:08:25+00:00","description":"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature","breadcrumb":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#primaryimage","url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg","contentUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/04\/BRA-1.jpg","width":1920,"height":1080,"caption":"xr:d:DAGB0iy_isI:24,j:6459711983316665026,t:24040810"},{"@type":"BreadcrumbList","@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/www.thema-med.com\/en\/"},{"@type":"ListItem","position":2,"name":"BRAZIL: B-GMP Extended to Four Years"}]},{"@type":"WebSite","@id":"https:\/\/www.thema-med.com\/en\/#website","url":"https:\/\/www.thema-med.com\/en\/","name":"Thema Med","description":"Quality and Regulatory Affairs for Medical Devices","publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thema-med.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place"],"@id":"https:\/\/www.thema-med.com\/en\/#organization","name":"Thema","alternateName":"Thema","url":"https:\/\/www.thema-med.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","contentUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","width":2440,"height":2851,"caption":"Thema"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/"],"mainEntityOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/04\/17\/brasile-estensione-a-quattro-anni-dei-b-gmp\/"}},{"@type":"Person","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d","name":"ufficiomarketing","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g","caption":"ufficiomarketing"},"url":"https:\/\/www.thema-med.com\/en\/author\/ufficiomarketing\/"}]}},"_links":{"self":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/32415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/users\/115"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/comments?post=32415"}],"version-history":[{"count":2,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/32415\/revisions"}],"predecessor-version":[{"id":32417,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/32415\/revisions\/32417"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media\/32373"}],"wp:attachment":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media?parent=32415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/categories?post=32415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/tags?post=32415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}